Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Guièze

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Blood|October 30, 2025
How far can ibrutinib resonate?Romain Guièze
Current Opinion in Oncology|July 7, 2025
Richter transformation: biological insights, diagnostic challenges and emerging therapiesRomain Guièze
Bulletin Du Cancer|April 26, 2021
[Richter Syndrome: Diagnostic and Therapeutic Management]Carolyne Croizier, Romain Guièze
Blood|June 13, 2015
Genomic and epigenomic heterogeneity in chronic lymphocytic leukemiaRomain Guièze, Catherine J Wu
La Revue Du Praticien|June 23, 2025
[Chronic lymphocytic leukaemia]Carolyne Croizier, Romain Guièze, Olivier Tournilhac
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic LeukemiaGregory Lazarian, Romain Guièze, Catherine J Wu
Cancer Cell|November 15, 2017
SnapShot: Chronic Lymphocytic LeukemiaElisa Ten Hacken, Romain Guièze, Catherine J Wu
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies in onco-hematology: Applications and perspectives]Sabrina Barrière, Nathan El-Ghazzi, Manon Garcia, et al.
Bulletin Du Cancer|August 11, 2011
[Histone deacetylase inhibitors in the treatment of hematological malignancies]Richard Lemal, Aurélie Ravinet, Cécile Moluçon-Chabrot, et al.
Bulletin Du Cancer|August 30, 2013
[Ruxolitinib prescription in myelofibrosis]Richard Lemal, Marie Robin, Aurélie Ravinet, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Blood|October 30, 2025
How far can ibrutinib resonate?Romain Guièze
Current Opinion in Oncology|July 7, 2025
Richter transformation: biological insights, diagnostic challenges and emerging therapiesRomain Guièze
Bulletin Du Cancer|April 26, 2021
[Richter Syndrome: Diagnostic and Therapeutic Management]Carolyne Croizier, Romain Guièze
Blood|June 13, 2015
Genomic and epigenomic heterogeneity in chronic lymphocytic leukemiaRomain Guièze, Catherine J Wu
La Revue Du Praticien|June 23, 2025
[Chronic lymphocytic leukaemia]Carolyne Croizier, Romain Guièze, Olivier Tournilhac
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic LeukemiaGregory Lazarian, Romain Guièze, Catherine J Wu
Cancer Cell|November 15, 2017
SnapShot: Chronic Lymphocytic LeukemiaElisa Ten Hacken, Romain Guièze, Catherine J Wu
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies in onco-hematology: Applications and perspectives]Sabrina Barrière, Nathan El-Ghazzi, Manon Garcia, et al.
Bulletin Du Cancer|August 11, 2011
[Histone deacetylase inhibitors in the treatment of hematological malignancies]Richard Lemal, Aurélie Ravinet, Cécile Moluçon-Chabrot, et al.
Bulletin Du Cancer|August 30, 2013
[Ruxolitinib prescription in myelofibrosis]Richard Lemal, Marie Robin, Aurélie Ravinet, et al.
Pageof 7